[1. Bowers LD. Therapeutic monitoring for cyclosporine: Difficulties in establishing a therapeutic window. Clin Biochem. 1991; 24:81-7.10.1016/0009-9120(91)90315-6]DOI öffnenSearch in Google Scholar
[2. Armstrong VW, Oellerich M. New developments in the immunosuppressive drug monitoring of cyclosporine, tacrolimus, and azathioprine. Clin Biochem. 2001 34:9-16.10.1016/S0009-9120(00)00175-2]DOI öffnenSearch in Google Scholar
[3. Nowack R. Review article: cytochrome P450 enzyme, and transport protein mediated herb-drug interactions in renal transplant patients: grapefruit juice, St John’s Wort - and beyond!. Nephrology (Carlton). 2008;13:337-47.10.1111/j.1440-1797.2008.00940.x]DOI öffnenSearch in Google Scholar
[4. Paine MF, Widmer WW, Pusek SN, Beavers KL, Criss AB, Snyder J, et al. Further characterization of a furanocoumarin-free grapefruit juice on drug disposition: studies with cyclosporine. Am J Clin Nutr. 2008; 87:863-71.10.1093/ajcn/87.4.863]Search in Google Scholar
[5. Guo L-Q, Fukuda K, Ohta T, Yamazoe Y. Role of Furanocoumarin Derivatives on Grapefruit Juice- Mediated Inhibition of Human CYP3A Activity. Drug Metab Dispos. 2000; 28:766-71.]Search in Google Scholar
[6. Fukuda K, Ohta T, Yamazoe Y. Grapefruit component interacting with rat and human P450 CYP3A: possible involvement of non-flavonoid components in drug interaction. Biol Pharm Bull. 1997; 20:560-4.10.1248/bpb.20.560]DOI öffnenSearch in Google Scholar
[7. Fukuda K, Ohta T, Oshima Y, Ohashi N, Yoshikawa M, Yamazoe Y. Specific CYP3A4 inhibitors in grapefruit juice: furocoumarin dimers as components of drug interaction. Pharmacogenetics. 1997; 7:391-6.10.1097/00008571-199710000-00008]DOI öffnenSearch in Google Scholar
[8. He K, Iyer KR, Hayes RN, Sinz MW, Woolf TF, Hollenberg PF. Inactivation of Cytochrome P450 3A4 by Bergamottin, a Component of Grapefruit Juice. Chem Res Toxicol. 1998; 11:252-9.10.1021/tx970192k]DOI öffnenSearch in Google Scholar
[9. Tassaneeyakul W, Guo L-Q, Fukuda K, Ohta T, Yamazoe Y. Inhibition Selectivity of Grapefruit Juice Components on Human Cytochromes P450. Archives of Biochemistry and Biophysics. 2000; 378:356-63.10.1006/abbi.2000.1835]DOI öffnenSearch in Google Scholar
[10. Edwards DJ, Bernier SM. Naringin and naringenin are not the primary CYP3A inhibitors in grapefruit juice. Life Sciences. 1996; 59:1025-30.10.1016/0024-3205(96)00417-1]DOI öffnenSearch in Google Scholar
[11. Honda Y, Ushigome F, Koyabu N, Morimoto S, Shoyama Y, Uchiumi T, et al. Effects of grapefruit juice and orange juice components on P-glycoproteinand MRP2-mediated drug efflux. Br J Pharmacol. 2004; 143:856-64.10.1038/sj.bjp.0706008157594115504753]DOI öffnenSearch in Google Scholar
[12. Lim S-L, Lim L-Y. Effects of citrus fruit juices on cytotoxicity and drug transport pathways of Caco-2 cell monolayers. Int J Pharm. 2006; 307:42-50.10.1016/j.ijpharm.2005.09.017]DOI öffnenSearch in Google Scholar
[13. Romiti N, Tramonti G, Donati A, Chieli E. Effects of grapefruit juice on the multidrug transporter Pglycoprotein in the human proximal tubular cell line HK-2. Life Sciences. 2004; 76:293-302.10.1016/j.lfs.2004.06.015]DOI öffnenSearch in Google Scholar
[14. Ohnishi A, Matsuo H, Yamada S, Takanaga H, Morimoto S, Shoyama Y, et al. Effect of furanocoumarin derivatives in grapefruit juice on the uptake of vinblastine by Caco-2 cells and on the activity of cytochrome P450 3A4. Br J Pharmacol. 2000; 130: 1369-77.10.1038/sj.bjp.0703433]Search in Google Scholar
[15. Takanaga H, Ohnishi A, Yamada S, Matsuo H, Morimoto S, Shoyama Y, et al. Polymethoxylated Flavones in Orange Juice Are Inhibitors of Pglycoprotein but Not Cytochrome P450 3A4. J Pharmacol Exp Ther. 2000; 293:230-6.]Search in Google Scholar
[16. Egashira K, Ohtani H, Itoh S, Koyabu N, Tsujimoto M, Murakami H, et al. Inhibitory effects of pomelo on the metabolism of tacrolimus and the activities of CYP3A4 and P-glycoprotein. Drug Metab Dispos. 2004; 32:828-33.10.1124/dmd.32.8.828]DOI öffnenSearch in Google Scholar
[17. Edwards DJ, Fitzsimmons ME, Schuetz EG, Yasuda K, Ducharme MP, Warbasse LH, et al. 6',7'- dihydroxybergamottin in grapefruit juice and seville orange juice: effects on cyclosporine disposition, enterocyte CYP3A4, and p-glycoprotein. Clin Pharmacol Ther. 1999; 65:237-44.10.1016/S0009-9236(99)70102-5]DOI öffnenSearch in Google Scholar
[18. Malhotra S, Bailey DG, Paine MF, Watkins PB. Seville orange juice-felodipine interaction: Comparison with dilute grapefruit juice and involvement of furocoumarins[ast]. Clin Pharmacol Ther. 2001; 69: 14-23.10.1067/mcp.2001.11318511180034]DOI öffnenSearch in Google Scholar
[19. Hou Y-C, Hsiu S-L, Tsao C-W, Wang Y-H, Chao P-DL. Acute incation of toxication of cyclosporin caused by coadministration of decoctions of the fruits of Citrus aurantium and the pericarps of Citrus grandis. Planta Med. 2000; 66:653-5.10.1055/s-2000-862211105574]DOI öffnenSearch in Google Scholar
[20. Grenier J, Fradette C, Morelli G, Merritt GJ, Vranderick M, Ducharme MP. Pomelo juice, but not cranberry juice, affects the pharmacokinetics of cyclosporine in humans. Clin Pharmacol Ther. 2006; 79:255-62.10.1016/j.clpt.2005.11.01016513449]DOI öffnenSearch in Google Scholar
[21. Castillo JREd, Elsener J, Martineau GP. Pharmacokinetic modeling of in-feed tetracyclines in pigs using a meta-analytic compartmental approach. Swine Health Prod. 1998; 6:189-202.]Search in Google Scholar
[22. Bistrup C, Nielsen FT, Jeppesen UE, Dieperink H. Effect of grapefruit juice on Sandimmun Neoral(R) absorption among stable renal allograft recipients. Nephrol Dial Transplant. 2001; 16:373-7.10.1093/ndt/16.2.37311158415]Search in Google Scholar
[23. Herlitz H, Edgar B, Hedner T, Lidman K, Karlberg I. Grapefruit juice: a possible source of variability in blood concentration of cyclosporin A. Nephrol Dial Transplant. 1993; 8:375.]Search in Google Scholar
[24. Min DI, Ku YM, Perry PJ, Ukah FO, Ashton K, Martin MF, et al. Effect of grapefruit juice on cyclosporine pharmacokinetics in renal transplant patients. Transplantation Proceedings. 1996; 62: 123-5.10.1097/00007890-199607150-000238693526]DOI öffnenSearch in Google Scholar
[25. Proppe DG, Hoch OD, McLean AJ, Visser KE. Influence of chronic ingestion of grapefruit juice on steady-state blood concentrations of cyclosporine A in renal transplant patients with stable raft function. Br J Clin Pharmacol. 1995; 39:337-8.10.1111/j.1365-2125.1995.tb04459.x]DOI öffnenSearch in Google Scholar
[26. Proppe DG, Visser KE, Bartels R, Hoch OD, Meyer H, McLean AJ. Grapefruit juice selectively modifies cyclosporin A metabolite patterns in renal transplant patients. Clinic Pharmacol Ther. 1996; 59:138.10.1038/sj.clpt.1996.50]DOI öffnenSearch in Google Scholar
[27. Ducharme MP, Provenzano R, Dehoorne-Smith M, Edwards DJ. Trough concentrations of cyclosporine in blood following administration with grapefruit juice. Br J Clin Pharmacol. 1993; 36:457-9.10.1111/j.1365-2125.1993.tb00395.x]DOI öffnenSearch in Google Scholar
[28. Ducharme MP, Warbasse LH, Edwards DJ. Disposition of intravenous and oral cyclosporine after administration with grapefruit juice. Clin Pharmacol Ther. 1995; 57:485-91.10.1016/0009-9236(95)90032-2]DOI öffnenSearch in Google Scholar
[29. Ku YM, Min DI, Flanigan M. Effect of grapefruit juice on the pharmacokinetics of microemulsion cyclosporine and its metabolite in healthy volunteers: does the formulation difference matter?. J Clin Pharmacol. 1998; 38:959-65.10.1002/j.1552-4604.1998.tb04393.x]DOI öffnenSearch in Google Scholar
[30. Lee M, Min DI, Ku YM, Flanigan M. Effect of grapefruit juice on pharmacokinetics of microemulsion cyclosporine in African American subjects compared with Caucasian subjects: does ethnic difference matter? J Clin Pharm. 2001; 41:317-23.10.1177/00912700122010131]DOI öffnenSearch in Google Scholar
[31. Schwarz UI, Johnston PE, Bailey DG, Kim RB, Mayo G, Milstone A. Impact of citrus soft drinks relative to grapefruit juice on ciclosporin disposition. Br J Clin Pharmacol. 2005; 62:485-91.10.1111/j.1365-2125.2005.02519.x]DOI öffnenSearch in Google Scholar
[32. Yee GC, Stanley DL, Pessa LJ, Costa TD, Beltz SE, Ruiz J, et al. Effect of grapefruit juice on blood cyclosporin concentration. Lancet. 1995; 345:955-6.10.1016/S0140-6736(95)90700-9]DOI öffnenSearch in Google Scholar
[33. Brunner LJ, Pai KS, Munar MY, Lande MB, Olyaei AJ, Mowry JA. Effect of grapefruit juice on cyclosporin. A pharmacokinetics in pediatric renal transplant patients. Pediatr Transplant. 2000; 4:313-21.10.1034/j.1399-3046.2000.00136.x]DOI öffnenSearch in Google Scholar
[34. Hollander AA, van Rooij J, Lentjes GW, Arbouw F, van Bree JB, Schoemaker RC, et al. The effect of grapefruit juice on cyclosporine and prednisone metabolism in transplant patients. Clin Pharmacol Ther. 1995; 57:318-24.10.1016/0009-9236(95)90157-4]DOI öffnenSearch in Google Scholar
[35. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary?. Controlled Clin Trials. 1996; 17: 1-12.10.1016/0197-2456(95)00134-4]DOI öffnenSearch in Google Scholar
[36. Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997; 315:629-34.10.1136/bmj.315.7109.629]DOI öffnenSearch in Google Scholar
[37. Begg CB, Mazumdar M. Operating Characteristics of a Rank Correlation Test for Publication Bias. Biometrics. 1994; 50:1088-101.10.2307/2533446]DOI öffnenSearch in Google Scholar
[38. Ameer B, Weintraub RA. Drug interactions with grapefruit juice. Clin Pharmacokinet. 1997; 33:103-21.10.2165/00003088-199733020-00003]DOI öffnenSearch in Google Scholar
[39. Bailey DG, Arnold JM, Spence JD. Grapefruit juice and drugs. How significant is the interaction? Clin Pharmacokinet. 1994; 26:91-8.10.2165/00003088-199426020-00002]DOI öffnenSearch in Google Scholar
[40. Dahan A, Altman H. Food-drug interaction: grapefruit juice augments drug bioavailability:mechanism, extent and relevance. Eur J Clin Nutr. 2004; 58:1-9.10.1038/sj.ejcn.1601736]DOI öffnenSearch in Google Scholar
[41. Haddad A, Davis M, Lagman R. The pharmacological importance of cytochrome CYP3A4 in the palliation of symptoms: review and recommendations for avoiding adverse drug interactions. Supportive Care Cancer. 2007; 15:251-7.10.1007/s00520-006-0127-5]Search in Google Scholar
[42. Hebert MF. Contributions of hepatic and intestinal metabolism and P-glycoprotein to cyclosporine and tacrolimus oral drug delivery. Adv Drug Deliv Rev. 1997; 27:201-14.10.1016/S0169-409X(97)00043-4]DOI öffnenSearch in Google Scholar
[43. Huang S-M, Hall SD, Watkins P, Love LA, Serabjit- Singh C, Betz JM, et al. Drug Interactions with Herbal Products and Grapefruit Juice: A Conference Report[ast]. Clin Pharmacol Ther. 2004; 75:1-12.10.1016/j.clpt.2003.07.00214749688]DOI öffnenSearch in Google Scholar
[44. Ioannides C. Drug-phytochemical interactions. Inflammopharmacology. 2003; 11:7-42.10.1163/15685600332154710315035733]DOI öffnenSearch in Google Scholar
[45. Kane GC, Lipsky JJ. Drug-grapefruit juice interactions. Mayo Clin Proc. 2000; 75:933-42.10.4065/75.9.933]DOI öffnenSearch in Google Scholar
[46. Lo A, Burckart GJ. P-glycoprotein and drug therapy in organ transplantation. J Clin Pharmacol. 1999; 39: 995-1005.10.1177/00912709922011755]DOI öffnenSearch in Google Scholar
[47. Mertens-Talcott SU, Zadezensky I, De Castro WV, Derendorf H, Butterweck V. Grapefruit-Drug Interactions: Can Interactions With Drugs Be Avoided?. J Clin Pharmacol. 2006; 46:1390-416.10.1177/0091270006294277]DOI öffnenSearch in Google Scholar
[48. Schmidt LE, Dalhoff K. Food-drug interactions. Drugs [Review]. 2002; 62:1481-502.10.2165/00003495-200262100-00005]Search in Google Scholar
[49. Zhou SF, Lim LY, Chowbay B. Herbal modulation of P-glycoprotein. Drug Metab Rev. 2004; 36:57-104.10.1081/DMR-120028427]DOI öffnenSearch in Google Scholar
[50. Saito M, Hirata-Koizumi M, Matsumoto M, Urano T, Hasegawa R. Undesirable effects of citrus juice on the pharmacokinetics of drugs: Focus on recent studies. Drug Safety. 2006; 28:677-94.10.2165/00002018-200528080-00003]DOI öffnenSearch in Google Scholar
[51. Bailey DG. Sun drop citrus soda and cyclosporine interaction: comments on causality and recommendations. Transplant Proc. 2005; 79:747.10.1097/01.TP.0000148914.13844.D9]DOI öffnenSearch in Google Scholar
[52. Johnston A, Holt DW. Comment on: Lancet. 1995 Apr 15;345(8955):955-6. Effect of grapefruit juice on blood cyclosporin concentration. Lancet. 1995; 346: 122-3.10.1016/S0140-6736(95)92146-X]Search in Google Scholar
[53. Paine MF, Oberlies NH. Clinical relevance of the small intestine as an organ of drug elimination: drug-fruit juice interactions. Expert Opin Drug Metab Toxicol. 2007; 3:67-80.10.1517/17425255.3.1.6717269895]Search in Google Scholar
[54. Rodriguez-Proteau R, Mata JE, Miranda CL, Fan Y, Brown JJ, Buhler DR. Plant polyphenols and multidrug resistance: effects of dietary flavonoids on drug transporters in Caco-2 and MDCKII-MDR1 cell transport models. Xenobiotica. 2006; 36:41-58.10.1080/0049825050043354516507512]Search in Google Scholar
[55. Fang SH, Hou YC, Hsiu SL, Chao PDL. Effects of Citrus grandis peels on cyclosporin concentration and immune responses in mice. J Food Drug Anal. 2006; 14:166-73.]Search in Google Scholar
[56. Wang M, Hou Y-C, Tsai S, Hsiu S-L, Wen K, Chao P-DL. Effects of coadministrations of unripe fruits and ripe peels of Citrus aurantium on cyclosporine pharmacokinetics in rats. JFDA. 2007; 15:265-70.]Search in Google Scholar
[57. Hou YC. Effects of citrus herbs on cyclosporin pharmacokinetics in rats and pigs (PDM-P-121). FIP World Congress. 2002; 62:48.]Search in Google Scholar
[58. Johnston PE, Milstone A. Probable interaction of bergamottin and cyclosporine in a lung transplant recipient. Transplant Proc. 2005; 79:746.10.1097/01.TP.0000148913.75002.33]DOI öffnenSearch in Google Scholar
[59. Mehrsai AR, Pourmand G, Mansour D, Zand S, Rezaali A. Effect of grapefruit juice on serum concentration of cyclosporine in Iranian renal transplant patients. Transplant Proc. 2003; 35: 2739-41.10.1016/j.transproceed.2003.08.080]DOI öffnenSearch in Google Scholar
[60. Sorkhi H, Moghadamnia AA, Oaliaee F, Pouramir M, Firoozjahi AR, Pasha AA, et al. Effect of tangerine juice on cyclosporine levels in renal transplant children. Pediatr Nephrol. 2008; 23:499-501.10.1007/s00467-007-0655-3]DOI öffnenSearch in Google Scholar
[61. Sorkhi H, Oliaei F, Moghadamnia AA, Pouramin M, Firoozjahi AR. Effect of Orange and Tangerine Juice on Cyclosporine Levels in Renal Transplant Recipients. Transplant Proc. 2007; 39:1228-30.10.1016/j.transproceed.2007.03.040]DOI öffnenSearch in Google Scholar
[62. Brunner LJ, Munar MY, Vallian J, Wolfson M, Stennett DJ, Meyer MM, et al. Interaction between cyclosporine and grapefruit juice requires long-term ingestion in stable renal transplant recipients. Pharmacotherapy. 1998; 18:23-9.]Search in Google Scholar
[63. Hermann M, Asberg A, Reubsaet JL, Sather S, Berg KJ, Christensen H. Intake of grapefruit juice alters the metabolic pattern of cyclosporin A in renal transplant recipients. Int J Clin Pharmacol Ther. 2002; 40:451-6.10.5414/CPP40451]DOI öffnenSearch in Google Scholar
[64. Emilia G, Longo G, Bertesi M, Gandini G, Ferrara L, Valenti C. Clinical Interaction Between Grapefruit Juice and Cyclosporine: Is There any Interest for the Hematologists?. Blood. 1998; 91:362-3.10.1182/blood.V91.1.362]Search in Google Scholar
[65. Akhlaghi F, Trull AK. Distribution of Cyclosporin in Organ Transplant Recipients. Clin Pharmacokinet. 2002; 41:615-37.10.2165/00003088-200241090-00001]DOI öffnenSearch in Google Scholar
[66. Fukuda K, Guo L, Ohashi N, Yoshikawa M, Yamazoe Y. Amounts and variation in grapefruit juice of the main components causing grapefruit-drug interaction. J Chromatogr B Biomed Sci Appl. 2000; 741:195-203.10.1016/S0378-4347(00)00104-3]DOI öffnenSearch in Google Scholar
[67. Friman S, Baeckman L. A new microemulsion formulation of cyclosporin: Pharmacokinetic and clinical features. Clin Pharmacokinet. 1996; 30:181-93.10.2165/00003088-199630030-000018882300]DOI öffnenSearch in Google Scholar
[68. Lohitnavy M, Lu Y, Lohitnavy O. A pharmacokinetic model of the gastrointestinal tract consisting of two segments can describe the concentration-time course of itraconazole. Int J Clin Pharmacol Ther. 2006; 44: 394-6.10.5414/CPP4439416961171]DOI öffnenSearch in Google Scholar
[69. Lohitnavy M, Lu Y, Lohitnavy O, Chubb LS, Hirono S, Yang RSH. A Possible Role of Multidrug Resistance- Associated Protein 2 (Mrp2) in Hepatic Excretion of PCB126, an Environmental Contaminant: PBPK/PD Modeling. Toxicol Sci. 2008; 104:27-39.10.1093/toxsci/kfn02618281255]Search in Google Scholar
